Clinical risk factors of bevacizumab-related hypertension in patients with metastatic colorectal cancer: a retrospective study

IntroductionBevacizumab, a vascular endothelial growth factor (VEGF) inhibitor, is widely used as a first-line treatment for metastatic colorectal cancer (mCRC), with hypertension being a common adverse effect. However, there is limited data on the predisposing factors contributing to bevacizumab-in...

Olles dieđut

Furkejuvvon:
Bibliográfalaš dieđut
Váldodahkkit: Zhuoling Zheng (Dahkki), Yihong Zhao (Dahkki), Jingwen Xie (Dahkki), Min Gao (Dahkki), Yiting Wang (Dahkki), Xiaoyan Li (Dahkki)
Materiálatiipa: Girji
Almmustuhtton: Frontiers Media S.A., 2024-10-01T00:00:00Z.
Fáttát:
Liŋkkat:Connect to this object online.
Fáddágilkorat: Lasit fáddágilkoriid
Eai fáddágilkorat, Lasit vuosttaš fáddágilkora!

Interneahtta

Connect to this object online.

3rd Floor Main Library

oažžasuvvan: 3rd Floor Main Library
Hildobáiki: A1234.567
Njađus 1 Oažžumis